Why AI matters at this scale

Siteman Cancer Center, part of Barnes-Jewish Hospital and Washington University School of Medicine, is a National Cancer Institute-designated comprehensive cancer center. It provides a full spectrum of oncology services—from prevention and diagnosis to treatment and survivorship—anchored in cutting-edge academic research. With over 1,000 employees, it operates at a scale where manual processes and data silos create significant inefficiencies, while the complexity and volume of cancer care generate vast, underutilized clinical data.

For an organization of this size and mission, AI is not a luxury but a strategic imperative to maintain its leadership position. It represents a force multiplier for its research enterprise and a critical tool for improving patient outcomes and operational excellence. At this mid-to-large enterprise scale, Siteman has the data assets and institutional resources to pilot and scale AI solutions, but may lack the dedicated AI infrastructure and agile culture of pure tech companies. Implementing AI can directly address core challenges: personalizing therapy for complex diseases, managing escalating costs, and accelerating the translation of research breakthroughs into clinical practice.

Concrete AI Opportunities with ROI Framing

1. Precision Oncology & Clinical Trial Matching: AI algorithms can continuously analyze electronic health records (EHRs), genomic data, and scientific literature to recommend personalized treatment pathways and match eligible patients to clinical trials. The ROI is multi-faceted: improved patient outcomes through targeted therapies, increased trial enrollment revenue for the academic institution, and enhanced reputation as an innovation hub.

2. Diagnostic Imaging Augmentation: Deploying AI-powered radiology assistants for tumor detection and measurement in imaging scans (CT, MRI). This reduces radiologist workload, minimizes diagnostic variability, and speeds up reporting times. The financial return comes from increased throughput, potentially reduced errors, and the ability to handle growing imaging volumes without proportional increases in staffing.

3. Operational Predictive Analytics: Machine learning models can forecast daily patient volumes, predict no-shows, and optimize scheduling for infusion chairs, operating rooms, and imaging equipment. This directly improves asset utilization, reduces patient wait times, and increases net revenue per available resource. The ROI is highly quantifiable in terms of increased capacity and reduced overtime costs.

Deployment Risks Specific to This Size Band

Organizations in the 1,001-5,000 employee band face unique AI deployment risks. Integration Complexity is paramount; stitching AI tools into monolithic, mission-critical EHR systems (like Epic or Cerner) is expensive and disruptive. Change Management at this scale is difficult, requiring buy-in from hundreds of physicians, nurses, and administrators accustomed to established workflows. Talent Scarcity is acute; competing with tech giants and startups for top AI/ML talent strains budgets, often leading to reliance on external vendors and consultants, which creates lock-in and knowledge transfer risks. Finally, Data Governance becomes exponentially harder; unifying and curating high-quality, de-identified data from dozens of departments across a large hospital system is a monumental task that must precede any effective AI model training.